FIBRINOLYSIS DECREASED

This adverse event was reported 1 times

FIBRINOLYSIS DECREASED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ECALLANTIDE 1 0.0005
1 DANAZOL 1 0.0004
2 ELETRIPTAN HYDROBROMIDE 1 0.0001
3 CICLESONIDE 1 0.0001
4 METHOCARBAMOL 1 0.0000
5 MOMETASONE FUROATE 1 0.0000
6 LIDICAINE 1 0.0000
7 LIDOCAINE, MENTHOL 1 0.0000
8 LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 1 0.0000
9 LIDOCAINE 4% 1 0.0000
See all drugs enriched for association with FIBRINOLYSIS DECREASED

FIBRINOLYSIS DECREASED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
1 Androgen [EPC] 1 0.0000
2 Muscle Relaxant [EPC] 1 0.0000
3 Ester Local Anesthetic [EPC] 1 0.0000
4 Non-Standardized Chemical Allergen [EPC] 1 0.0000
5 Catecholamine [EPC] 1 0.0000
6 Amide Local Anesthetic [EPC] 1 0.0000
7 Antiarrhythmic [EPC] 1 0.0000
8 Expectorant [EPC] 1 0.0000
9 Progestin [EPC] 1 0.0000
See all drug classes enriched for association with FIBRINOLYSIS DECREASED